Descarga: Oral anticoagulation with edoxaban Archivo: tromboembolia-venosa/haemo_2012-oral anticoagulation with edoxabanpdf.pdf Edoxaban (the former DU176b) an orally available direct factor Xa inhibitor has been engineered from DX-9065a, which was one of the first parenteral Xa inhibitors. Edoxaban has a time to peak plasma concentrations of 1–2 hours and a half-life of approximately 10 hours after multiple…

Descarga: Newlocations of intravascular tissue factor Archivo: tromboembolia-venosa/tvp/haemo_2007-New locations of intravascular tissue factor .pdf Tissue factor (TF) is the major initiator of blood coagulation, and a mediator of inflammation, angiogenesis, and carcinogenesis. According to recent evidence, preformed TF and inducible expression of the protein is observed in several blood components. TF is apparently constitutively expressed…

Descarga: Management of bleeding with oral anticoagulants in patients with atrial fibrillation Archivo: tromboembolia-venosa/tvp/haemo_2015-Management of bleeding with oral anticoagulants in.pdf Fear of bleeding is a common barrier to the use of anticoagulants.  Warfarin has been the only oral anticoagulant for more than 60 years and warfarin-related bleeding is reported to be the most common drug-related…